Package 61703-304-36

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 61703-304-36
Digits Only 6170330436
Product NDC 61703-304
Product ID 61703-304_412ed3cc-fefa-4665-9f00-cf118fd55b6f
Description

1 VIAL, MULTI-DOSE in 1 CARTON (61703-304-36) / 25 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 1994-02-28
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

Cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "412ed3cc-fefa-4665-9f00-cf118fd55b6f", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["240416"], "spl_set_id": ["21e8e8e6-3f85-4fdd-8452-c9d14d2ef69a"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (61703-304-36)  / 25 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "61703-304-36", "marketing_start_date": "19940228"}], "brand_name": "Cytarabine", "product_id": "61703-304_412ed3cc-fefa-4665-9f00-cf118fd55b6f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "61703-304", "generic_name": "CYTARABINE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA072945", "marketing_category": "ANDA", "marketing_start_date": "19940228", "listing_expiration_date": "20261231"}